References
Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B (2007) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 2007 Aug 3, [Epub ahead of print]
Coleman RE (2000) Management of bone metastases. Oncologist 5:463–470
van Beek E, Pieterman E, Cohen L, Lowik C, Papapoulos S (1999) Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo. Biochem Biophys Res Commun 255:491–494
Powles T, McCloskey E, Kurkilahti M (2004) Oral clodronate for adjuvant treatment of operable breast cancer: results of a randomized, double-blind, placebo-controlled multicenter trial. Fortieth Annual Meeting of American Society of Clinical Oncology, New Orleans, USA, June 5–8, 2004. Proc Am Soc Clin Oncol 22:(abst 528)
Jaschke A, Bastert G, Solomayer EF, Costa S, Schuetz F, Diel IJ (2004) Adjuvant clodronate treatment improves the overall survival of primary breast cancer patients with micrometastases to bone marrow—a longtime follow-up. Fortieth Annual Meeting of American Society of Clinical Oncology, New Orleans, USA, June 5–8, 2004. Proc Am Soc Clin Oncol 22:(abst 529)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harputluoglu, H., Dizdar, O., Karaahmet, F. et al. Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors. Breast Cancer Res Treat 110, 541 (2008). https://doi.org/10.1007/s10549-007-9735-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-007-9735-0